You are here: Industry Insights > Bayer

News List

Bayer animal health sale could rake in $8B and bids from private equity fiercepharma
March 20, 2019
Ever since last November, when Bayer ended months of speculation and confirmed it would be casting off its animal health unit, investors have been waiting for details.
Bayer's Ph III clinical trial of Nifurtimox in pediatric patients with Chagas Disease meets primary endpoint biospectrumasia
March 18, 2019
Chagas is an infectious disease caused by a parasite (Trypanosoma cruzi) and transmitted to humans via the feces of triatomines, also known as kissing bugs.
Bayer's Ph III clinical trial of Nifurtimox in pediatric patients with Chagas Disease meets primary endpoint biospectrumasia
March 15, 2019
Chagas is an infectious disease caused by a parasite (Trypanosoma cruzi) and transmitted to humans via the feces of triatomines, also known as kissing bugs.
Darolutamide submitted for EU approval pharmatimes
March 12, 2019
Orion Corporation and Bayer have submitted a marketing application in Europe for use of darolutamide in patients with a certain type of prostate cancer.
Impact pioneers honored for groundbreaking ideas in the fields of healthcare and nutrition worldpharmanews
March 08, 2019
The Bayer Cares Foundation recently presented the 2018 Aspirin Social Innovation Awards to five international initiatives for their groundbreaking ideas in the fields of healthcare and nutrition.
Takeda ordered to pay Bayer $155M for hemophilia patent infringement fiercepharma
February 24, 2019
It may not be what Takeda bargained for with its massive Shire buyout, but early into its ownership of the rare disease specialist, a jury ordered the Japanese drugmaker to pay hemophilia rival Bayer $155 million for patent infringement.
Bayer, Geisinger add digital touch to office-visit contraception chat fiercepharma
February 24, 2019
Bayer and Geisinger Health are teaming up to put contraception front and center in women's health visits, starting with some information gathering before a patient sets foot in the clinic.
Marketing With safety data, Bayer could challenge Erleada, Xtandi in prostate cancer fiercepharma
February 24, 2019
For years, Johnson & Johnson and the Pfizer-Astellas team have been the only players in their class of prostate-cancer fighters. But Bayer is waiting in the wings, and stellar new safety data could make it a threat.
Pipeline-hungry Bayer antes up on Vitrakvi, just as Roche’s would-be rival gets faster FDA review fiercepharma
February 24, 2019
Eager to pump up its pipeline—and hungry for present-day sales—Bayer has taken its chance to carve a piece out of Eli Lilly's $8 billion Loxo Oncology buyout.
Bayer pairs its products in first-ever portfolio TV ad for hormone-releasing IUDs fiercepharma
February 24, 2019
Bayer is taking on myths about intrauterine devices (IUDs) in a new two-product ad campaign. The first-ever campaign featuring both the Mirena and Kyleena branded IUDs recently began as Bayer looks to not only explain what the levonorgestrel-releasing IUD

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page